World Journal of
Pharmaceutical and Life Sciences

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Indian Science Publications, SOCOLAR, China, Cosmos Impact Factor, Research Bible, Fuchu, Tokyo. JAPAN, Scientific Indexing Services (SIS), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Scientific Indexing, UAE, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Indian citation Index (ICI), IFSIJ Measure of Journal Quality, International Scientific Indexing, UAE (ISI), Web of Science Group (Under Process), Directory of Research Journals Indexing, 

Abstract

PERCUTANEOUS CORONARY INTERVENTION BY BIORESORBABLE SCAFFOLDS: ABOUT TWO CASES AT THE CARDIOLOGY DEPARTMENT OF THE ARISTIDE LE DANTEC HOSPITAL-SENEGAL.

Hariniaina Ravaoavy*, Joseph Salvador Mingou, Mouhamadou Bamba Ndiaye, Simon Antoine Sarr, Fatou Aw, Malick Bodian, Adama Kane, Maboury Diao and Serigne Abdou Ba.

ABSTRACT

The Bioresorbable Vascular Scaffold (BVS) is a transitional support for the vessel, allowing it to heal and return to a natural state after resorption. We studied two patients who underwent percutaneous coronary intervention (PCI) with a BVS in the cardiology unit of the teaching hospital Aristide Le Dantec, Dakar Senegal. The first patient was a 76-year-old male with several cardiovascular risk factors. He presented with an ST-segment elevation myocardial infarction within thrombolysis delay. Coronarography showed a sub-occlusion of the left anterior descending artery (LAD). A PCI using a BVS was performed with good clinical outcome and no intra-stent restenosis after 6 months. The second was a 43-year-old woman with no cardiovascular risk factors. She presented with the same clinical case as the first patient. A PCI using a BVS was performed with good clinical outcome but got complicated with an intra-stent restenosis at 6th month follow-up. These were the first PCI using BVS performed in the service or even in sub-Saharan Africa to our knowledge. The stents were MAGMARIS. The procedure followed the guidelines for the use of BVS. Restenosis in the second patient despite well-managed treatment is consistent with data in the literature on BVS, which do not recommend their use outside of clinical trials.

[Full Text Article]

BEST PAPER AWARDS

World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .

Best Article of current issue

Download Article : Click here